Dose Effect Evaluation and Therapeutic Window of the Neuro-EPO Nasal Application for the Treatment of the Focal Ischemia Model in the Mongolian Gerbil
Figure 8
After 7 days of models of focal ischemia. = Significance with regard to vehicle, indicating a significant difference in the U test of Mann and Whitney. ( per group). Dose Neuro-EPO IN 249.4 UI.